Landos Biopharma, Inc. (LABP) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 52 transactions totaling $59.7M, demonstrating a bullish sentiment with $53.1M in net insider flow. The most recent transaction on Feb 28, 2023 involved a sale of 786,299 shares valued at $0.
No significant insider buying has been recorded for LABP in the recent period.
No significant insider selling has been recorded for LABP in the recent period.
Based on recent SEC filings, insider sentiment for LABP is bullish with an Insider Alignment Score of 95/100 and a net flow of $53.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Landos Biopharma, Inc. (LABP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading LABP stock, having executed 52 transactions in the past 90 days. The most active insider is Advisors Llc Perceptive (Executive), who has made 12 transactions totaling $23.2M.
Get notified when executives and directors at LABP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | Bassaganya-riera Josep | Executive | Sale | 786,299 | $N/A | $0 | |
| Feb 28, 2023 | Bassaganya-riera Josep | Executive | Sale | 500,000 | $N/A | $0 | |
| Feb 28, 2023 | Bassaganya-riera Josep | Executive | Sale | 496,527 | $N/A | $0 | |
| Feb 28, 2023 | Bassaganya-riera Josep | Executive | Sale | 3,470,736 | $N/A | $0 | |
| Feb 28, 2023 | Bassaganya-riera Josep | Executive | Sale | 467,306 | $N/A | $0 | |
| Sep 23, 2022 | Lp Rtw Investments, | Executive | Sale | 300,000 | $0.69 | $207.0K | |
| Aug 5, 2022 | Bassaganya-riera Josep | Executive | Gift | 500,000 | $N/A | $0 | |
| Aug 5, 2022 | Bassaganya-riera Josep | Executive | Gift | 500,000 | $N/A | $0 | |
| Mar 23, 2022 | Bassaganya-riera Josep | Executive | Gift | 650,000 | $N/A | $0 | |
| Dec 28, 2021 | Bassaganya-riera Josep | Executive | Gift | 1,000,000 | $N/A | $0 | |
| Dec 20, 2021 | Bassaganya-riera Josep | Executive | Sale | 33,194 | $4.75 | $157.7K | |
| Dec 17, 2021 | Bassaganya-riera Josep | Executive | Sale | 36,000 | $4.84 | $174.2K | |
| Dec 16, 2021 | Bassaganya-riera Josep | Executive | Sale | 24,301 | $5.11 | $124.2K | |
| Dec 16, 2021 | Bassaganya-riera Josep | Executive | Gift | 58,651 | $N/A | $0 | |
| Dec 15, 2021 | Bassaganya-riera Josep | Executive | Sale | 43,000 | $5.02 | $215.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 15 | $56.4M | 94.2% |
Sale(S) | 22 | $3.3M | 5.5% |
Exercise(M) | 1 | $219.6K | 0.4% |
Gift(G) | 7 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insiders at Landos Biopharma, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 52 transactions totaling $56.4M in purchases versus $3.3M in sales, the net buying activity of $53.1M signals strong executive confidence. Advisors Llc Perceptive (Executive) leads the buying activity with $23.2M in transactions across all time.